Skip to main content
. 2018 Dec 27;18:702. doi: 10.1186/s12879-018-3617-4

Table 1.

Epidemiology, clinical findings, and diagnostic methodology of aspergillus thyroiditis

Epidemiology
n (%) Age (year-old) Primary aspergillus locations
11-30 31-60 61-78 Thyroid gland Lung/ airway
12 (41.4) 10 (34.5) 7 (24.1) 12 (41.4) 13 (44.8)
Comorbidities Transplantation SLE MDS NHL ALL AML AIDS Chronic granulomatous disease Polymyalgia Skin disease Diabetes No comorbidity
n (%) 9 (29.0) 5 (16.1) 4 (12.9) 3 (9.7) 2 (6.5) 2 (6.5) 1 (3.2) 1 (3.2) 1 (3.2) 1 (3.2) 1 (3.2) 1 (3.2)
Clinical findings
Symptoms Fever Dyspneaa Dysphagia Neck pain Neck erythema/ warmth Tachycardia Cough Phlegm Neurological sign
n (%) 25 (86.2) 15 (51.7) 2 (6.9) 14 (48.3) 4 (13.8) 8 (27.6) 5 (17.2) 3 (10.3) 9 (31.0)
Manifestation of thyroid Enlargement Nodule Hemorrhage Thyrotoxicosis Euthyroid sick syndrome Hyperthyroidism Hypothyroidism Euthyroidism
n (%) 22 (75.9) 10 (34.5) 2 (6.9) 12 (41.4) 1 (3.4) 13 (44.8) 2 (6.9) 6 (20.7)
Diagnostic methodology
Imaging Culture Others
Scintigraphy Thyroid-CT/ Ultrasound Lung-X ray/ CT Thyroid punctured liquid/ swab/ tissue Sputum/ airway secretion Blood Urine/ body fluid/ other tissue Galactomannan test Histological test Fine needle aspiration
Positive,
n (%)
6 (85.7) 18 (100) 17 (68) 12 (85.7) 6 (33.3) 1 (9.1) 5 (41.7) 5 (55.6) 14 (93.3) 13 (86.7)

aincluding dyspnea/ shortness of breath/ respiratory insufficiency/ airway compromise